peptide hormone is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-08-30. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
== Research == Preliminary research suggests that topical finasteride may be effective in the treatment of pattern hair loss. Topical finasteride, like the oral preparation, reduces serum DHT. DHT may be involved in the cause of acne, and 5α-reductase inhibitors might be effective in the treatment of the condition. A small retrospective study reported that finasteride was effective in the treatment of acne in women with normal testosterone levels. A randomized controlled trial found that finasteride was less effective than flutamide or an ethinylestradiol/cyproterone acetate birth control pill in the treatment of acne in women with high androgen levels. Androgens and estrogens may be involved in the cause of hidradenitis suppurativa (acne inversa). Two case series have reported that finasteride is effective in the treatment of hidradenitis suppurativa in girls and women. Finasteride and other antiandrogens might be useful in the treatment of obsessive–compulsive disorder (OCD), but more research is needed.
Church's Texas Chicken is an American fast food restaurant chain that specializes in Southern fried chicken and is headquartered in Atlanta, Georgia. The chain was founded as Church's Fried Chicken To-Go by George W. Church Sr. in April 1952, in San Antonio, Texas, across the street from The Alamo. Church's Texas Chicken trades as Texas Chicken or Church's Chicken in many countries. The chain is owned by an American private equity firm known as High Bluff Capital Partners. As of 2017, Church's Texas Chicken had more than 1,700 franchised and company-owned locations in 26 countries.
At the age of 19 he was assigned to war work in the Operational Research Section (ORS) of RAF Bomber Command, where he developed analytical methods for calculating the ideal density for bomber formations to help the Royal Air Force bomb German targets during the Second World War. After the war, Dyson was readmitted to Trinity College, where he obtained a BA degree in mathematics. From 1946 to 1949 he was a fellow of his college, occupying rooms just below those of the philosopher Ludwig Wittgenstein, who resigned his professorship in 1947. In 1947 Dyson published two papers in number theory. Friends and colleagues described him as shy and self-effacing, with a contrarian streak that his friends found refreshing but intellectual opponents found exasperating. "I have the sense that when consensus is forming like ice hardening on a lake, Dyson will do his best to chip at the ice", Steven Weinberg said of him. His friend the neurologist and author Oliver Sacks said: "A favourite word of Freeman's about doing science and being creative is the word 'subversive'. He feels it's rather important not only to be not orthodox, but to be subversive, and he's done that all his life."
Sources: en.wikipedia.org
Founded in 1945, Wellcome is Hong Kong's longest-established supermarket chain. Since 1964, the company has been wholly owned by Dairy Farm International Holdings following the merger with rival supermarket Dairy Lane. Wellcome has an overall staff of 5,000 in more than 240 stores and serves more than 14 million customers every month. Wellcome was established in 1945 by Mr. Wu Chung-Wai, Mr. Lau Lim and Mr. Ko Yin-Yu. Wellcome established its first store on Ice House Street in Central. The shop specialised in imported products including wines, biscuits, canned food and beverages. Wellcome was the first supermarket to establish a Home Delivery Service division, and an average of 600 customers enjoyed this one-of-a-kind service through orders in person daily. Wellcome was acquired by Dairy Farm(Now DFI Retail Group) in 1964. The company was the first to introduce a "self-service" retailing concept. Customers no longer require the assistance of service staff to get products; they have to select products from the shelf. Wellcome was the first to offer pre-packaged rice products in 1973. In the 1980s, Wellcome launched its first corporate brand "No Frills", offering customers over 300 products at the lowest prices as compared to other products in the same category. Later, Wellcome became the first supermarket to employ Electronic data interchange (EDI) technology to improve the efficiency of operation. Wellcome expanded to Taiwan and acquired Ding Hao supermarket. Wellcome opened its first 24-hour store in Great George Street, Causeway Bay on 23 October 1998.
== Career == In 1992, Ülgen joined the faculty at Boğaziçi University as in instructor in the department of chemical engineering. She was promoted to assistant professor in 1994, associate professor in 1996, and professor in 2002. She served as head of the chemical engineering department from 2009 to 2011. Ülgen served as associate dean of the faculty of engineering from 2012 to December 2015. Ülgen researches pharmacophore modelling to identify pharmacological chaperones to treat infectious diseases, genetic diseases, and cancer. She uses a systems biology approach to investigate the reconstruction of signaling networks in yeast, worms, and humans. She also researches protein purification, computational physiology, and metabolic pathway engineering.
elementary reaction Any chemical reaction in which one or more chemical species react directly to form products in a single reaction step and with a single transition state, i.e. without any intermediates. Contrast stepwise reaction.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.